로딩 중…
지수 로딩 중…
Castle Biosciences, Inc.
CSTL· NASDAQ· Health Care· Health Care Equipment & Services
$21.12+4.30%
2026-06-18
Price Chart
Castle Biosciences, Inc.+11.69%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $641M |
| Revenue | $340M |
| Net Income | $-13M |
| Total Assets | $548M |
| Net Assets | $461M |
| Value | |
| P/B | 1.39x |
| P/S | 1.88x |
| FCF Yield | 0.71% |
| Profitability | |
| ROE | -2.78% |
| ROA | -2.34% |
| Op. Margin | -9.79% |
| Revenue Growth | -4.90% |
| Earnings Growth | -232.41% |
| Financial Health | |
| Debt Ratio | 18.72% |
| Total Debt | $37M |
| FCF | $5M |
| Cash | $64M |
| Current Ratio | 6.75x |
| Performance | |
| 1Y Return | 11.69% |
| 1M Return | 10.00% |
| From 52W High | -52.30% |
| 1Y MDD | -57.83% |
| Trading | |
| Volume | 705,001 shares |
| Trading Value | $15M |
| Per Share | |
| EPS | $-0.82 |
| BPS | $16.05 |